Apeiron Therapeutics opens US headquarter

Written By Fred Aswad

Apeiron Therapeutics opens US headquarter in the San Francisco Bay Area. The Bay Area office will enable Apeiron to tap into the deep expertise and talent pool at the intersection of biotechnology and artificial intelligence in the Bay Area and in the broader US. Fred Aswad, Ph.D., J.D., and Vice President of Biology will lead the US efforts.

Fred Aswad
Previous

GT Apeiron Therapeutics Strengthens Advisory Board
Next

Apeiron founded and announces its partnership with Exscientia